<DOC>
	<DOCNO>NCT01121471</DOCNO>
	<brief_summary>The purpose study determine role CLA complementary therapy improve body composition , glucose tolerance , fast plasma glucose insulin , hemoglobinA1c ( HbA1c ) subject type 2 diabetes mellitus ( T2DM ) .</brief_summary>
	<brief_title>Supplementation With Conjugated Linoleic Acid ( CLA ) Complementary Therapy Management Type 2 Diabetes Mellitus ( Women 's Diabetes Study )</brief_title>
	<detailed_description>The design double-blind , placebo-controlled , crossover study conduct single site . The primary variable change baseline Week 16 plasma glucose area curve three-hour oral glucose tolerance test . Secondary variable include change fast level glucose insulin , glucose tolerance , hemoglobinA1c , hepatic enzyme , adipocytokines , blood lipid profile , body composition . Supporting endpoint include dietary intake , physical activity , fatty acid , vital sign .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>diagnosis Type 2 diabetes mellitus obese postmenopausal HbA1c &gt; 6.49 &lt; 14.1 use tobacco substance abuse impair cognitive function renal disease abnormal liver function gastrointestinal disease use exogenous insulin use hormone replacement therapy currently within past 6 month pacemaker/defibrillator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>diabetes</keyword>
	<keyword>conjugate linoleic acid</keyword>
</DOC>